5d 1m 3m 1y 5y 10y
There are 4 articles on this stock available only to PRO subscribers.
CMXI vs. ETF Alternatives
Cytomedix, Inc. develops and commercializes innovative autologous therapies that promote healing by harnessing the innate and regenerative capacity of platelets and adult stem cells.
Country: United States